Similarly, a panel comprising antibodies to the autoantigens, p53, c-myc, human epidermal growth factor receptor 2 (HER2), New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1), cancer/testis antigen gene (CAGE), Mucin 1 (MUC1), and GBU4-5, achieved high sensitivity and specificity for the detection of squamous cell lung cancers [90]. This evidence concerns the gene TP53 and squamous cell lung carcinoma.